share_log

Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market

Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market

Regeneron製藥公司股價週三上漲，表現仍遜於大盤
DowjonesNews MarketWatch ·  2021/09/22 17:19

This article was automatically generated by MarketWatch using technology from Automated Insights.

本文由MarketWatch使用Automated Insights的技術自動生成。

Shares of Regeneron Pharmaceuticals Inc. (REGN) inched 0.02% higher to $647.06 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.95% to 4,395.64 and the Dow Jones Industrial Average  rising 1.00% to 34,258.32. This was the stock's second consecutive day of gains. Regeneron Pharmaceuticals Inc. closed $39.56 short of its 52-week high ($686.62), which the company achieved on September 3rd.

Regeneron製藥公司(Regeneron PharmPharmticals Inc.)股價週三小幅上漲0.02%，至647.06美元，股市全面上漲，標準普爾500指數(S&P500 Index)上漲0.95%，至4,395.64點，道瓊斯工業平均指數(Dow Jones Industrial Average)上漲1.00%，至34,258.32點。這是該股連續第二個交易日上漲。Regeneron製藥公司(Regeneron PharmPharmticals Inc.)的收盤價比該公司9月3日創下的52周高點(686.62美元)低39.56美元。

The stock outperformed some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 0.36% to $163.93, Novartis AG ADR (NOVN.EB) fell 0.30% to $82.80, and Amgen Inc. (AMGN) fell 0.80% to $213.64. Trading volume (556,867) remained 167,268 below its 50-day average volume of 724,135.

該股週三表現優於部分競爭對手，強生(JNJ)跌0.36%，報163.93美元，諾華製藥美國存託憑證(NOVN.EB)跌0.30%，報82.8美元，安進(AMGN)跌0.80%，報213.64美元。成交量(556,867口)仍比50天平均成交量724,135口低167,268口。

Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2021.

數據來源：道瓊斯市場數據，FactSet。數據彙編於2021年9月22日。

-MarketWatch Automation

-MarketWatch自動化

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論